Kanyos Bio, Inc., A Wholly-owned Subsidiary Of Anokion Sa

This study tested whether KAN-101 could protect people with celiac disease from intestinal damage caused by gluten exposure. Fifty-five adults who follow a strict gluten-free diet received either the experimental drug or a placebo, then underwent a controlled gluten challenge. Re…